CLICK THE PICTURE TO VOTE
COVID-19

Coronavirus: European Medicines Agency reviews Sinovac vaccine

(Reuters) – The European Medicines Agency (EMA) said Tuesday that it has begun a “real-time” review of a COVID-19 vaccine candidate from Chinese biotech company Sinovac Biotech based on preliminary results.

The data on this vaccine will be assessed as they become available under an emergency permit, the European Union’s health authority said.

At this stage, the EMA has approved a COVID-19 vaccine from the Pfizer-BioNtech alliance, as well as from Moderna, AstraZeneca and Johnson & Johnson.

(Pushkala Aripaka in Bangalore; French version by Claude Chengju, edited by Blandine Heno)

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker